Autolus Therapeutics plc (AUTL) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 529.62M |
| Enterprise Value | 777.07M |
| P/E Ratio | -1.68 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 4.04 |
| Price/Book Ratio | 6.33 |
| Enterprise/Revenue | 3.29 |
| Enterprise/EBITDA | -1.74 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -2.39 |
| Operating Margin | -2.11 |
AD
Management Effectiveness
| Return On Assets | -0.57 |
| Return On Equity | -1.79 |
Income Statement
| Revenue | 75.56M |
| Revenue/Share | 0.44 |
| Gross Profit | -21.03M |
| EBITDA | -250.26M |
| Net Income | -288.2M |
| Diluted EPS | -1.08 |
Balance Sheet
| Total Cash | 201.63M |
| Total Cash/Share | 0.76 |
| Total Debt | 83.51M |
| Total Debt/Equity | 1.12 |
| Current Ratio | 4.89 |
| Book Value Per Share | 0.28 |
Price History
| 52-Week Change | 10.56 |
| 52-Week High | 2.58 |
| 52-Week Low | 1.18 |
| Moving Average 50 Days | 2.02 |
| Moving Average 200 Days | 1.67 |
Statistics
| Average Volume | 2.06M |
| Shares Outstanding | 266.14M |
| % Held by Institutions | 49.67 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
